Japan's Love for Genentech’s Xofluza Flu Treatment May Be Waning

Japan's Love for Genentech’s Xofluza Flu Treatment May Be Waning

Source: 
BioSpace
snippet: 

When the U.S. Food and Drug Administration (FDA) approved Genentech’s Xofluza, a single-dose treatment for the flu, it was met with great fanfare, particularly in Japan, where the treatment was first discovered.